Cardiff Oncology, Inc. CRDF
Set alert
0.84 USD -0.05 -5.09%
At close · Nov 2
0.84 0.00 0.00%
After hours · Nov 2, 4:00 PM ET
0.8333 Day range 0.91
0.76 52-week range 3.31
- YTD
- -69.95%
- 1 year
- -64.07%
- Open
- 0.8982
- Prev close
- 0.8896
- Mkt cap
- 65.68M
- Vol
- 467.44K
- Avg vol
- 661.02K
- EPS
- -0.60
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 0.8333
- High
- 0.91
- Forward P/E
- -4.03
- Beta
- 1.93
- Short ratio
- 8.06
- Inst. own
- 27.66%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 3.08
- 200-d avg
- 3.20
- 1y target
- 10.75
5D chart
Signals (137)
| Name | Time | Ago |
|---|---|---|
| SMA: Bullish | Nov 2, 10:25 AM | 17 hours ago |
| SMA: Bearish | Nov 2, 10:20 AM | 17 hours ago |
| SMA: Bullish | Nov 2, 9:55 AM | 18 hours ago |
| MACD: Buy Signal | Nov 2, 9:55 AM | 18 hours ago |
| SMA: Bullish | Nov 2, 9:40 AM | 18 hours ago |
| SMA: Bearish | Nov 2, 9:35 AM | 18 hours ago |
| MACD: Sell Signal | Nov 2, 9:35 AM | 18 hours ago |
| SMA: Bearish | Nov 2, 9:30 AM | 18 hours ago |
| SMA: Bullish | Oct 30, 3:50 PM | 3 days ago |
| SMA: Bearish | Oct 30, 3:45 PM | 3 days ago |
| SMA: Bullish | Oct 30, 3:15 PM | 3 days ago |
| MACD: Buy Signal | Oct 30, 3:10 PM | 3 days ago |
| SMA: Bullish | Oct 30, 3:05 PM | 3 days ago |
| SMA: Bearish | Oct 30, 2:50 PM | 3 days ago |
| SMA: Bullish | Oct 30, 2:40 PM | 3 days ago |
| RSI: Oversold | Oct 30, 2:30 PM | 3 days ago |
| MACD: Sell Signal | Oct 30, 1:35 PM | 3 days ago |
| SMA: Bearish | Oct 30, 1:30 PM | 3 days ago |
| SMA: Bullish | Oct 30, 1:15 PM | 3 days ago |
| SMA: Bearish | Oct 30, 1:05 PM | 3 days ago |
Newest 20 of 137.
Analyst view
Consensus: strong buy
Strong buy
Price target (mean) 10.75 +1173.2% upside
Now 0.8443
- Target (low)
- 10.00
- Target (mean)
- 10.75
- Target (high)
- 13.00
Ratings (0m) 5 5 buy · 0 hold · 0 sell
- Strong buy2
- Buy3
- Hold0
- Sell0
- Strong sell0
Recommendation trend
- This month 5
- 1 month ago 5
- 2 months ago 5
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.24667 | -0.29 – -0.20 | -0.21 | -17.5% | 73.00K | -53.2% | 3 |
| Next quarter | -0.25 | -0.31 – -0.21 | -0.22 | -13.6% | 76.00K | -62.9% | 3 |
| Current year | -0.98667 | -1.03 – -0.93 | -0.93 | -6.1% | 592.80K | +21.5% | 3 |
| Next year | -1.02 | -1.32 – -0.83 | -0.98667 | -3.0% | 322.00K | -45.7% | 3 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Dec 13, 2024 | Piper Sandler | Maintained | Overweight | Overweight |
| Nov 8, 2024 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Sep 6, 2024 | Craig-Hallum | Initiated | — | Buy |
| May 6, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Mar 6, 2024 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Mar 1, 2024 | Piper Sandler | Maintained | Overweight | Overweight |
| Aug 11, 2023 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Aug 8, 2023 | HC Wainwright & Co. | Maintained | Buy | Buy |
| May 9, 2023 | HC Wainwright & Co. | Maintained | — | Buy |
| Mar 29, 2023 | HC Wainwright & Co. | Reiterated | — | Buy |
| Mar 7, 2023 | HC Wainwright & Co. | Maintained | — | Buy |
| Sep 16, 2022 | HC Wainwright & Co. | Maintained | — | Buy |
| Sep 13, 2022 | Piper Sandler | Maintained | — | Overweight |
| Aug 29, 2022 | Baird | Maintained | — | Outperform |
| May 9, 2022 | HC Wainwright & Co. | Maintained | — | Buy |
| Feb 28, 2022 | HC Wainwright & Co. | Maintained | — | Buy |
| Dec 8, 2021 | Baird | Initiated | — | Outperform |
| Aug 10, 2021 | HC Wainwright & Co. | Maintained | — | Buy |
| May 10, 2021 | HC Wainwright & Co. | Maintained | — | Buy |
| Oct 22, 2020 | HC Wainwright & Co. | Initiated | — | Buy |
| Oct 8, 2020 | Piper Sandler | Initiated | — | Overweight |
| Sep 18, 2020 | Maxim Group | Maintained | — | Buy |